- Home
- SPHL vs BDRX Comparison
SPHL vs BDRX Comparison
Compare SPHL & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPHL | BDRX |
|---|---|---|
| Founded | 2002 | 2000 |
| Country | Singapore | United Kingdom |
| Employees | 71 | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 4.0M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | SPHL | BDRX |
|---|---|---|
| Price | $2.35 | $2.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 144.8K | ★ 2.8M |
| Earning Date | 12-29-2025 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,956,226.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.31 | $2.55 |
| 52 Week High | $62.40 | $92.00 |
Technical Indicators
Market Signals| Indicator | SPHL | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.02 | 38.99 |
| Support Level | $2.31 | $4.55 |
| Resistance Level | $3.20 | $7.22 |
| Average True Range (ATR) | 0.58 | 1.49 |
| MACD | -0.21 | -0.28 |
| Stochastic Oscillator | 3.72 | 1.25 |
Price Performance
Historical ComparisonAbout SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.